Clinical characteristics | PDQ-4 ≥ 30 (N = 128) | PDQ-4 < 30 (N = 663) | X2/Z | P value |
---|---|---|---|---|
Gender | 0.581† | 0.446 | ||
Male | 69 | 333 | ||
Female | 59 | 330 | ||
Age [years] | − 2.244‡ | 0.025 | ||
Median | 23 | 25 | ||
IQR | 21–28 | 21–29 | ||
BMI [kg/m2] | − 0.969‡ | 0.332 | ||
Median | 20.59 | 21.19 | ||
IQR | 19.39–23.43 | 19.54–23.12 | ||
Onset age [years] (N = 598) | PDQ-4 ≥ 30 (N = 83) | PDQ-4 < 30 (N = 515) | − 0.509‡ | 0.611 |
Median | 8 | 8 | ||
IQR | 5–10 | 6–11 | ||
Impact age [years] (N = 542) | PDQ-4 ≥ 30 (N = 76) | PDQ-4 < 30 (N = 466) | − 0.436‡ | 0.663 |
Median | 12 | 12 | ||
IQR | 8–15 | 8–16 |